Abstract
There are limited data on the use of extracorporeal membrane oxygenation (ECMO) for pregnant and peripartum women with COVID-19 associated acute respiratory distress syndrome (ARDS). Pregnant women may exhibit more severe infections with COVID-19, requiring intensive care. We supported nine pregnant or peripartum women with COVID-19 ARDS with ECMO, all surviving and suffering no major complications from ECMO. Our case series demonstrates high-maternal survival rates with ECMO support in the management of COVID-19 associated severe ARDS, highlighting that these pregnant and postpartum patients should be supported with ECMO during this pandemic.
Original language | English (US) |
---|---|
Pages (from-to) | 132-136 |
Number of pages | 5 |
Journal | ASAIO Journal |
Volume | 67 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2021 |
Keywords
- Adult
- COVID-19/complications
- Critical Care
- Extracorporeal Membrane Oxygenation
- Female
- Humans
- Postpartum Period
- Pregnancy
- Respiratory Distress Syndrome/etiology
- SARS-CoV-2
- Survival Rate
- Young Adult
ASJC Scopus subject areas
- Bioengineering
- Biophysics
- Biomedical Engineering
- Biomaterials